This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

AstraZeneca PLC (AZN)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 9.22B 7.70B 7.57B 11.07B
Receivables 8.37B 8.43B 9.81B 10.89B
Inventories 1.91B 2.06B 1.85B 1.68B
Other Current Assets 40.00M 31.00M 25.00M 9.00M
Total Current Assets 20.34B 19.05B 23.51B 25.13B
Property, Plant & Equipment, Gross 14.91B 15.07B 15.31B 15.58B
Accumulated Depreciation & Depletion 9.09B 8.98B 8.88B 8.63B
Property, Plant & Equipment, Net 5.82B 6.09B 6.42B 6.96B
Intangibles 16.05B 16.45B 10.98B 12.16B
Other Non-Current Assets 2.51B 940.00M 543.00M 535.00M
Total Non-Current Assets 35.56B 34.49B 29.32B 31.00B
Liabilities & Shareholder Equity
Total Assets 55.90B 53.53B 52.83B 56.13B
Accounts Payable 10.36B 9.22B 8.98B 8.66B
Short Term Debt 1.79B 901.00M 1.99B 125.00M
Other Current Liabilities 3.90B 3.78B 4.79B 8.00B
Total Current Liabilities 16.05B 13.90B 15.75B 16.79B
Long Term Debt 8.59B 9.41B 7.34B 9.47B
Deferred Income Taxes 2.83B 2.58B 2.74B 3.14B
Other Non-Current Liabilities 5.18B 3.69B 3.53B 3.32B
Minority Interest 15.00M 30.00M 33.00M 28.00M
Total Non-Current Liabilities 16.62B 15.89B 13.83B 16.13B
Total Liabilities 32.68B 29.80B 29.58B 32.91B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 23.22B 23.74B 23.25B 23.21B
Common Par 315.00M 312.00M 323.00M 352.00M
Additional Paid In Capital 3.98B 3.50B 3.08B 2.67B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 16.96B 17.96B 17.89B 18.27B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 1.97B 1.96B 1.95B 1.92B
Total Capitalization 31.81B 33.15B 30.58B 32.68B
Total Equity 23.22B 23.74B 23.25B 23.21B
Total Liabilities & Stock Equity 55.90B 53.53B 52.83B 56.13B
Total Common Shares Outstanding 1.26B 1.25B 1.29B 1.41B
Preferred Shares 0.00 50.00K 50.00K 50.00K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 1.25B 1.26B 1.36B 1.44B
Diluted Weighted Shares Outstanding 1.25B 1.26B 1.37B 1.45B
Number of Employees 51500 51700 57200 61000
Number of Part-Time Employees 0 0 0 0
AZN News

Analysts Ratings for AZN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

Brokerage Partners

AZN Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs